] . (2013). A Phase 1 Study of Heat/Phenol-Killed, E. coli - Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy. Allergy, 68, 803-808. presented at the 06/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23621498
. (2013). A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy, 68(6), 803-8. presented at the 2013 Jun. doi:10.1111/all.12158
. (2013). Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo Controlled Multicenter Trial. J Allergy Clin Immunol, 131, 119-127.e1-7. presented at the 01/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23265698
. (2014). Atopic Dermatitis Increases the Effect of Exposure to Peanut Antigen in Dust on Peanut Sensitization and Likely Peanut Allergy. J Allergy Clin Immunol. presented at the 11/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25457149
. (2014). The Natural History of Egg Allergy in an Observational Cohort. J Allergy Clin Immunol, 133, 492-499. presented at the 02/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24636473
. (2016). Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness. Allergy, 71(11), 1552-1560. presented at the 2016 11. doi:10.1111/all.12895